Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
6.80
-0.01 (-0.15%)
Sep 30, 2025, 3:00 PM CST
SHA:603718 Revenue
Shanghai Hile Bio-Technology had revenue of 47.98M CNY in the quarter ending June 30, 2025, with 28.66% growth. This brings the company's revenue in the last twelve months to 273.22M, up 19.09% year-over-year. In the year 2024, Shanghai Hile Bio-Technology had annual revenue of 271.04M with 12.59% growth.
Revenue (ttm)
273.22M
Revenue Growth
+19.09%
P/S Ratio
16.32
Revenue / Employee
746.50K
Employees
366
Market Cap
4.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 271.04M | 30.32M | 12.59% |
Dec 31, 2023 | 240.72M | -59.27M | -19.76% |
Dec 31, 2022 | 299.99M | -47.30M | -13.62% |
Dec 31, 2021 | 347.29M | 88.16M | 34.02% |
Dec 31, 2020 | 259.13M | -18.86M | -6.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |